New
ScienceMore in Science →
Partial reprogramming is back at the center of the anti-ageing debate
A clinical trial targeting age-related vision disorders is renewing interest in partial reprogramming, a field that aims to rejuvenate damaged tissue without fully resetting cells to an embryonic state.
Key Takeaways
- A clinical trial in age-related vision conditions is renewing interest in partial reprogramming.
- The approach builds on the 2006 discovery of induced pluripotent stem cells.
DE
DT Editorial AI··via newscientist.com